Recent topics related to etiology and clinical manifestations of cutaneous arteritis [PDF]
Frontiers in Medicine, 2022 Cutaneous polyarteritis nodosa (cPAN) was first reported by Lindberg in 1931. It has been recognized as a skin-limited vasculitis whose cutaneous histopathological features are indistinguishable from those of PAN.
Takaharu Ikeda
exaly +4 more sources
Safety of Immune Checkpoint Inhibitors in Cancer Patients With Preexisting Autoimmune Vasculitis [PDF]
ACR Open RheumatologyObjective Immune checkpoint inhibitors (ICIs) are effective cancer therapies but often cause serious immune‐related adverse events (irAEs). Patients with preexisting autoimmune diseases, including vasculitis, are excluded from trials.
Juan Sevillano +4 more
doaj +3 more sources
Focal vascular occlusion: A link between livedoid vasculopathy and cutaneous arteritis?
JEADV Clinical Practice, 2023 Background Livedoid vasculopathy (LV) and cutaneous arteritis (CA) are rare cutaneous diseases. A consideration of these two conditions as different entities is debatable, because thrombosis and inflammation are closely related in their pathogenesis ...
G R Nagy +2 more
exaly +2 more sources
Cutaneous arteritis with compartment syndrome: Case report and review of published works
Journal of Cutaneous Immunology and Allergy, 2021 Cutaneous arteritis (CA) is a rare limited form of polyarteritis nodosa (PAN), which usually has a benign prognosis and requires less aggressive therapy.
Satoshi Yoshida +2 more
exaly +2 more sources
Cutaneous arteritis: Clinicopathological study of 21 cases
Journal of Cutaneous Immunology and Allergy, 2023 Objectives We conducted this study to clarify the progress of cutaneous arteritis. Methods We examined 21 cases of cutaneous arteritis that were diagnosed at our hospital between 2005 and 2020.
Tomoko Hiraiwa +2 more
exaly +2 more sources
Takayasu and Giant Cell Arteritis Unmasked by Vedolizumab as Paradoxical Reactions: Two Case Reports. [PDF]
ACR Open RheumatolACR Open Rheumatology, Volume 8, Issue 3, March 2026.
Aoki T +6 more
europepmc +2 more sources
Therapeutic Advances in Musculoskeletal Disease, 2019 Background: New-onset sarcoidosis has been previously described in three case reports in patients affected by rheumatoid arthritis treated with tocilizumab (TCZ). The existence of a cause–effect mechanism between the biological treatment and the onset of
Rosaria Del Giorno, Luca Gabutti
exaly +2 more sources
Is macular lymphocytic arteritis limited to the skin? Long-term follow-up of seven patients, [PDF]
Anais Brasileiros de Dermatologia, 2020 Background: Macular lymphocytic arteritis most commonly presents as hyperpigmented macules on the lower limbs. The pathogenesis of this disease is still unclear and there is an ongoing debate regarding whether it represents a new form of cutaneous ...
Thâmara Cristiane Alves Batista Morita +2 more
doaj +1 more source
Serologic Abnormalities in Macular Lymphocytic Arteritis with Case Presentation
Case Reports in Dermatology, 2022 Macular lymphocytic arteritis (MLA) is an indolent cutaneous small-medium-vessel vasculitis characterized by widespread asymptomatic livedo racemosa. A number of serologic abnormalities have been reported including an elevated erythrocyte sedimentation ...
Nicole R. Bender +4 more
doaj +1 more source
Alteration of microbial composition in the skin and blood in vasculitis
Scientific Reports, 2023 Vasculitis is a systemic autoimmune disease characterized by leukocyte infiltration into blood vessels. Various microorganisms have been associated with the pathogenesis of vasculitis; however, the causal microbial agents and underlying mechanisms are ...
Ryujin Miyata +9 more
doaj +1 more source